Literature DB >> 10493881

Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.

D Lu1, K Fütterer, S Korolev, X Zheng, K Tan, G Waksman, J E Sadler.   

Abstract

Enteropeptidase is a membrane-bound serine protease that initiates the activation of pancreatic hydrolases by cleaving and activating trypsinogen. The enzyme is remarkably specific and cleaves after lysine residues of peptidyl substrates that resemble trypsinogen activation peptides such as Val-(Asp)4-Lys. To characterize the determinants of substrate specificity, we solved the crystal structure of the bovine enteropeptidase catalytic domain to 2.3 A resolution in complex with the inhibitor Val-(Asp)4-Lys-chloromethane. The catalytic mechanism and contacts with lysine at substrate position P1 are conserved with other trypsin-like serine proteases. However, the aspartyl residues at positions P2-P4 of the inhibitor interact with the enzyme surface mainly through salt bridges with the Nzeta atom of Lys99. Mutation of Lys99 to Ala, or acetylation with acetic anhydride, specifically prevented the cleavage of trypsinogen or Gly-(Asp)4-Lys-beta-naphthylamide and reduced the rate of inhibition by Val-(Asp)4-Lys-chloromethane 22 to 90-fold. For these reactions, Lys99 was calculated to account for 1.8 to 2.5 kcal mol(-1) of the free energy of transition state binding. Thus, a unique basic exosite on the enteropeptidase surface has evolved to facilitate the cleavage of its physiological substrate, trypsinogen. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493881     DOI: 10.1006/jmbi.1999.3089

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Intermolecular relaxation has little effect on intra-peptide exchange-transferred NOE intensities.

Authors:  Adam P R Zabell; Carol Beth Post
Journal:  J Biomol NMR       Date:  2002-04       Impact factor: 2.835

Review 2.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

3.  Protease specificity determination by using cellular libraries of peptide substrates (CLiPS).

Authors:  Kevin T Boulware; Patrick S Daugherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-03       Impact factor: 11.205

4.  Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.

Authors:  Maiken T Joergensen; Andrea Geisz; Klaus Brusgaard; Ove B Schaffalitzky de Muckadell; Péter Hegyi; Anne-Marie Gerdes; Miklós Sahin-Tóth
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

5.  Human enteropeptidase light chain: bioengineering of recombinants and kinetic investigations of structure and function.

Authors:  Eliot T Smith; David A Johnson
Journal:  Protein Sci       Date:  2013-03-26       Impact factor: 6.725

6.  Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency.

Authors:  Andreas Holzinger; Esther M Maier; Cornelius Bück; Peter U Mayerhofer; Matthias Kappler; James C Haworth; Stanley P Moroz; Hans-Beat Hadorn; J Evan Sadler; Adelbert A Roscher
Journal:  Am J Hum Genet       Date:  2001-11-21       Impact factor: 11.025

7.  Genomic characteristics of the T cell receptor (TRB) locus in the rabbit (Oryctolagus cuniculus) revealed by comparative and phylogenetic analyses.

Authors:  Rachele Antonacci; Francesco Giannico; Salvatrice Ciccarese; Serafina Massari
Journal:  Immunogenetics       Date:  2014-02-06       Impact factor: 2.846

8.  Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers.

Authors:  Sylvia Herter; Derek E Piper; Wade Aaron; Timothy Gabriele; Gene Cutler; Ping Cao; Ami S Bhatt; Youngchool Choe; Charles S Craik; Nigel Walker; David Meininger; Timothy Hoey; Richard J Austin
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

9.  Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry.

Authors:  Yonghao Yu; Matthew D Sweeney; Ola M Saad; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2006-02-28       Impact factor: 3.109

10.  Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.

Authors:  Andrea Geisz; Péter Hegyi; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2013-05-16       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.